MILTON, Ontario, May 16, 2016 /CNW/ -- Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) ("Aralez" or the "Company"), today announced that it has distributed its proxy statement and related meeting materials ("Meeting Materials") in connection with its upcoming 2016 Annual General Meeting of Shareholders (the "Annual Meeting") to be held on Thursday, June 16, 2016 at 1:00 p.m. ET at the offices of Stikeman Elliott LLP, 5300 Commerce Court West, 199 Bay Street, Toronto, ON, Canada M5L 1B9. The Meeting Materials are available on the Company's website at www.aralez.com, on EDGAR at www.sec.gov and on SEDAR at www.sedar.com.
About Aralez Pharmaceuticals Inc.
Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) is a global specialty pharmaceutical company focused on delivering meaningful products to improve patients' lives while creating shareholder value by acquiring, developing and commercializing products primarily in cardiovascular, pain and other specialty areas. Aralez's Global Headquarters is in Ontario, Canada, the U.S. Headquarters is planned to be in Princeton, NJ and the Irish Headquarters is in Dublin, Ireland. More information about Aralez can be found at www.aralez.com.
Aralez Pharmaceuticals US Inc.
Nichol L. Ochsner
Executive Director, Investor Relations & Corporate Communications
SOURCE Aralez Pharmaceuticals Inc.